Vestal Point Capital’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,625,000
Closed -$38.4M 76
2023
Q4
$38.4M Buy
+1,625,000
New +$38.4M 4.07% 9